These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 28733244)
1. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Abdelrahman FE; Elsayed I; Gad MK; Elshafeey AH; Mohamed MI Int J Pharm; 2017 Sep; 530(1-2):1-11. PubMed ID: 28733244 [TBL] [Abstract][Full Text] [Related]
2. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251 [TBL] [Abstract][Full Text] [Related]
3. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628 [TBL] [Abstract][Full Text] [Related]
4. Development of risperidone liposomes for brain targeting through intranasal route. Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571 [TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study. Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997 [TBL] [Abstract][Full Text] [Related]
6. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095 [TBL] [Abstract][Full Text] [Related]
7. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847 [TBL] [Abstract][Full Text] [Related]
8. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies. Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051 [TBL] [Abstract][Full Text] [Related]
9. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792 [TBL] [Abstract][Full Text] [Related]
10. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation. Hosny KM Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940 [TBL] [Abstract][Full Text] [Related]
11. Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation. M Elsharkawy F; M Amin M; A Shamsel-Din H; Ibrahim W; Ibrahim AB; Sayed S Int J Nanomedicine; 2023; 18():1577-1595. PubMed ID: 37007986 [TBL] [Abstract][Full Text] [Related]
12. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B; Khunt D; Misra M; Padh H Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Alex AT; Joseph A; Shavi G; Rao JV; Udupa N Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size. Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226 [TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment. Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655 [TBL] [Abstract][Full Text] [Related]
17. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289 [TBL] [Abstract][Full Text] [Related]
18. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333 [TBL] [Abstract][Full Text] [Related]
19. Optimization of topical curcumin spanlastics for melanoma treatment. Ismail S; Garhy D; Ibrahim HK Pharm Dev Technol; 2023 Jun; 28(5):425-439. PubMed ID: 37078715 [TBL] [Abstract][Full Text] [Related]
20. Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation. Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MM; Tayel SA Drug Dev Ind Pharm; 2018 Sep; 44(9):1443-1450. PubMed ID: 29614890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]